A new randomized clinical trial led by Sichuan University has found that taking antihypertensive medication at bedtime significantly improves nighttime blood pressure control compared to morning dosing. The study, published in JAMA Network Open, offers fresh insight into optimizing hypertension treatment through chronotherapy—timing medications based on the body’s biological clock.
Hypertension Remains a Pressing Health Issue
Hypertension continues to pose a serious global health threat. In China alone, nearly 300 million people suffer from high blood pressure, yet fewer than 17% manage to keep it under control. Among these patients, controlling nighttime blood pressure remains particularly challenging, despite it being a stronger predictor of heart attacks and strokes than daytime levels.
Mixed Results in Past Research
Earlier studies exploring the best time to administer antihypertensive medications have produced inconsistent findings. To address this, the research team designed a rigorous trial to clarify the impact of dosing time on nocturnal blood pressure and circadian rhythm regulation.
Trial Design and Methodology
Researchers conducted the study—titled “Morning vs. Bedtime Dosing and Nocturnal Blood Pressure Reduction in Patients With Hypertension: The OMAN Randomized Clinical Trial”—across 15 hospitals in China. The trial enrolled 720 adults aged 18 to 75 who were either untreated or had discontinued antihypertensive therapy for at least two weeks.
Medicalxpress reported that researchers randomly divided participants into two groups. One group took their medication in the morning (6:00–10:00 AM), while the other took it at bedtime (6:00–10:00 PM). Researchers gave all patients a combination pill of olmesartan (20 mg) and amlodipine (5 mg) and adjusted doses every four weeks based on ambulatory and clinic blood pressure measurements.
Bedtime Dosing Yields Superior Results
After 12 weeks, the bedtime dosing group showed a significantly greater reduction in nighttime systolic blood pressure. The between-group difference was -3.0 mm Hg (95% CI, -5.1 to -1.0 mm Hg). Nighttime diastolic pressure also dropped more in the bedtime group by -1.4 mm Hg (95% CI, -2.8 to -0.1 mm Hg).
Control rates for nighttime systolic pressure were notably higher in the bedtime group (79.0%) compared to the morning group (69.8%). Similarly, office systolic pressure control was better among those taking medication at night (88.7% vs. 82.2%).
Fewer Dose Escalations, No Added Risk
In addition to better blood pressure control, bedtime dosing resulted in fewer dosage increases. Importantly, the researchers found no significant rise in nocturnal hypotension or adverse events in either group, suggesting bedtime dosing is both effective and safe.
Guiding Future Hypertension Treatment
The study concludes that bedtime administration of antihypertensive medication improves nighttime blood pressure regulation and maintains 24-hour efficacy without increasing risks. These findings provide compelling support for bedtime dosing as a preferred strategy